跳至主要内容
临床试验/NCT03277833
NCT03277833已完成不适用

Efficacy and Safety of Gynostemma Pentaphyllum(Dungkulcha) Extract on Alleviation of Chronic Stress-induced Strain

Chonbuk National University Hospital0 个研究点目标入组 72 人开始时间: 2013年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
72
主要终点
Change in score of State&Trait version of STAI

研究概览

简要总结

The investigators performed a 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Gynostemma Pentaphyllum(Dungkulcha) on alleviation of chronic stress-induced strain. The investigators measured decrement of body fat parameters, State&Trait version of STAI, Beck Anxiety Inventory(BAI), Hamilton Anxiety Inventory(HAM-A), and monitored their blood pressure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 20-65 years with chronic stress( S-STAI score 40~60)

排除标准

  • excessive physically chronic fatigue
  • Subjects taking antidepressants, anxiolytics, hypnotics within the last 2 months prior to the study
  • Cardiovascular disease
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
  • Participation in any other clinical trials within past 2 months
  • Renal disease
  • Abnormal hepatic function
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • History of alcohol or substance abuse
  • Pregnancy or lacting women etc.

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Dietary Supplement)

Gynostemma Pentaphyllum(Dungkulcha) Extract

Experimental

Gynostemma Pentaphyllum(Dungkulcha) Extract (400mg/d)

干预措施: Gynostemma Pentaphyllum(Dungkulcha) Extract(400mg/day) (Dietary Supplement)

结局指标

主要结局

Change in score of State&Trait version of STAI

时间窗: Baseline and 8 weeks

Score of State\&Trait version of STAI was measured in study screening and visit 3(8 week).

次要结局

  • Change of Blood Norepinephrine Level(Baseline and 8 week)
  • Change of Blood Cortisol Level(Baseline and 8 week)
  • Change in score of Beck Anxiety Inventory(Baseline and 8 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo-Wan Chae

Principal Investigator, Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

相似试验